- Home
- CLOV vs YDES Comparison
CLOV vs YDES Comparison
Compare CLOV & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLOV | YDES |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 894.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLOV | YDES |
|---|---|---|
| Price | $1.98 | $8.18 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.35 | N/A |
| AVG Volume (30 Days) | ★ 5.8M | 25.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,371,131,000.00 | N/A |
| Revenue This Year | $41.68 | N/A |
| Revenue Next Year | $43.92 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.95 | $7.90 |
| 52 Week High | $4.52 | $25.00 |
Technical Indicators
Market Signals| Indicator | CLOV | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 32.15 | 28.57 |
| Support Level | N/A | N/A |
| Resistance Level | $2.78 | $13.19 |
| Average True Range (ATR) | 0.08 | 0.82 |
| MACD | 0.00 | -0.30 |
| Stochastic Oscillator | 10.42 | 3.39 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.